BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance

Molecular Cell

Volumn 8, Issue 4, 2001, Pages 795-806

  Slupianek, Artur ^a   Schmutte, Christoph ^b   Tombline, Gregory ^b   Nieborowska Skorska, Malgorzata ^a   Hoser, Grazyna ^c   Nowicki, Michal O ^a   Pierce, Andrew J ^d   Fishel, Richard ^b   Skorski, Tomasz ^a  

^a Temple University   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^d Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CASPASE 3; CISPLATIN; METHYLNITRONITROSOGUANIDINE; MITOMYCIN C; RAD51 PROTEIN; RECA PROTEIN;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; APOPTOSIS; ARTICLE; CELL LINE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HAMSTER; HUMAN; HUMAN CELL; MONKEY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

ANIMALIA; CRICETINAE; MAMMALIA;

EID: 0034760095     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(01)00357-4     Document Type: Article

References (46)

1. Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3
2. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain
3. BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: A mechanism of resistance to multiple anticancer agents
4. Synergistic actions of Rad51 and Rad52 in recombination and DNA repair
5. The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of rad51 and survival following treatment with the DNA cross-linking agent cisplatin
6. Homologous recombination as a mechanism of carcinogenesis
7. Xrcc3 is required for assembly of Rad51 complexes in vivo
8. Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl
9. Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia
10. Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL)
11. Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells
12. JAK-STAT signaling activated by Abl oncogenes
13. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein
14. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
15. BCR-ABL delays apoptosis upstream of procaspase-3 activation
16. Role of oncogenes in resistance and killing by cancer therapeutic agents
17. Signaling mismatch repair in cancer
18. Links between replication, recombination and genome instability in eukaryotes
19. Sequestration of mammalian Rad51-recombination protein into micronuclei
20. Role for caspase-mediated cleavage of Rad51 in induction of apoptosis by DNA damage
21. Homologous-pairing activity of the human DNA-repair proteins Xrcc3.Rad51C
22. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity
23. DNA repair and recombination factor rad51 is over-expressed in human pancreatic adenocarcinoma
24. v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells
25. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death
26. BRCA2 is required for homology-directed repair of chromosomal breaks
27. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: Role of Stat5 in proliferation
28. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis
29. ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block
30. In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene
31. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells
32. Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells
33. Coupled homologous and nonhomologous repair of double-strand break preserves genomic integrity in mammalian cells
34. Chronic myeloid leukemia
35. Characterization of the human Rad51 genomic locus and examination of tumors with 15q14-15 loss of heterozygosity (LOH)
36. Association of BRCA1 with Rad51 in mitotic and meiotic cells
37. Homologous recombination and the roles of double-strand breaks
38. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene
39. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells
40. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway
41. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death
42. Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs
43. Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation
44. Regulation of Rad51 function by c-Abl in response to DNA damage
45. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo